$SKYH

Gonzalez Francisco purchased $10K of SKYH

Gonzalez Francisco (Chief Financial Officer) purchased 1,000 shares of Sky Harbour Group Corp (SKYH) at $10.08 on 2026-09-11.

Original reporting
SEC EDGAR · Gonzalez Francisco
Published Sep 14, 2026, 11:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 12:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SKYH
Neutral
high confidence
Mentioned
$SKYH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SKYHNeutralLow
01

Why it matters

The purchase is too small to move the market but adds to the insider buying record for SKYH.

02

Market read

Low relevance; the filing is a routine insider purchase with minimal trading impact.

03

What to watch

Potential upcoming corporate actions not disclosed could motivate the purchase.

Relevance 4/10Novelty 2/10Timing: filed today

Background

Form 4 filings disclose insider transactions; CFO purchases are monitored for signals of confidence.

Company-level read

Ticker impact

$SKYHNeutralHigh confidence
Context

CFO Gonzalez Francisco bought 1,000 shares of Sky Harbour Group Corp for $10,080, a Form 4 filing disclosed today.

Expected impact

Minimal price movement expected; likely negligible effect on stock.

Evidence & confidence

The transaction amount is under $20k and represents a tiny fraction of total shares outstanding, so traders are unlikely to act.

Market effects

No significant implications for the maritime services sector.

Limited to US investors; no broader regional effect.

Not relevant to global markets.

Counterpoint

Some traders may view any insider buying as a bullish sign despite the small size.

Key entities

  • Gonzalez Francisco

    Chief Financial Officer of Sky Harbour Group Corp.

  • Sky Harbour Group Corp

    Operator of maritime logistics platforms, ticker SKYH.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SKYHMedAI 8/10

Sky Harbour announces $40 million equity financing deal

Sky Harbour Group (SKYH) entered a stock purchase agreement for a registered direct offering of 4,000,000 Class A common shares at $10.00 each, closing Aug. 12, 2026, for $40 million gross proceeds for general corporate purposes. A 90-day lock-up was agreed. Boston Omaha arranged a concurrent secondary sale of 360,000 shares at $10.00, expected to close Aug. 14, 2026.

$SKYHMed

Sky Harbour Announces Q2 Results and Updates on Leasing, Construction, Funding and Other Activities Reaffirms Guidance for Year End 2026

Sky Harbour Group Corp (SKYH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sky Harbour Announces Q2 Results and Updates on Leasing, Construction, Funding and Other Activities Reaffirms Guidance for Year End 2026 WEST HARRISON, N.Y.--( BUSINESS WIRE )--Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation

$SKYHMedAI 8/10

Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

Skyhawk Therapeutics reported 12-month cUHDRS subcomponent results from its Phase 1/2 trial of oral Huntington’s disease candidate SKY-0515. Mean changes vs expected worsening (from Enroll-HD propensity-weighted analyses) were favorable for TFC (+0.07 vs -0.87), TMS (-2.00 vs 2.21), SDMT (-0.19 vs -1.78), and SWRT (+3.44 vs -3.13). CGI/PGI showed no assessed worsening and 65% of participants/50% of clinicians reported improvement; mHTT blood reductions up to 69% and PMS1 mRNA up to 26%.